Integrating Medicine & Policy to Achieve Health care Transformation
Late Translational, health services and outcomes research is essential for improving patient care, enhancing population health, and shaping effective health care policy through rigorous evaluation and implementation of evidence-based strategies.
Our Mission: IMPACT builds a vibrant, productive community of clinician-scientists and PhD investigators at the Spencer Fox Eccles School of Medicine (SFESOM), dedicated to late translational (T3/T4), health services, and outcomes research. We foster a collaborative, supportive culture that emphasizes career development, mentorship, mutual support, and excellence to maximize our collective impact.
Our Vision: Transform health care and improve patient and population health outcomes by advancing innovative late translational (T3/T4), health services, and outcomes research that directly enhances patient care and shapes healthcare policy.
THE LATEST FROM IMPACT
Target Trial Emulation in Practice with CAUSALab
The IMPACT Program is pleased to announce a four-day, in-person workshop, Target Trial Emulation in Practice: A Causal Inference Workshop with CAUSALab, taking place Monday through Thursday, February 22-25, 2027.
This workshop is designed for clinicians, epidemiologists, biostatisticians, and health services and industry researchers. Familiarity with basic study design and data analysis is helpful.
LHS Orca Tank Pilot Competition
IMPACT is pleased to announce a call for proposals for the IMPACT Program Learning Health System Orca Tank Pilot Competition. The LHS Orca Tank supports learning health system demonstration projects that advance both operational and research goals. Projects may support implementation, evaluation, or use of other rigorous research methods that address a health system priority or need. IMPACT will match an operational or clinical partner's contribution, up to $25,000.
IMPACT Researcher Highlight: Dr. Valerie Vaughn
University of Utah Health has been awarded $30 million from the Patient-Centered Outcomes Research Institute (PCORI) to lead a large clinical study focused on identifying the most effective treatment for AWS. The study will compare phenobarbital, a newer treatment approach, with benzodiazepines, the established standard of care. Valerie Vaughn, MD, MS, Associate Director of IMPACT, will lead the study.